Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Molecular Characterization of a Novel Splicing Mutation Underlying Mucopolysaccharidosis (MPS) Type VI-Indirect Proof of Principle on Its Pathogenicity
Publication

Publications

Molecular Characterization of a Novel Splicing Mutation Underlying Mucopolysaccharidosis (MPS) Type VI-Indirect Proof of Principle on Its Pathogenicity

Title
Molecular Characterization of a Novel Splicing Mutation Underlying Mucopolysaccharidosis (MPS) Type VI-Indirect Proof of Principle on Its Pathogenicity
Type
Article in International Scientific Journal
Year
2020
Authors
Coutinho, MF
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Encarnacao, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Matos, L
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Silva, L
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Ribeiro, D
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Santos, JI
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Prata, MJ
(Author)
FCUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Vilarinho, L
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Alves, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Title: DiagnosticsImported from Authenticus Search for Journal Publications
Vol. 10
Final page: 58
Publisher: MDPI
Other information
Authenticus ID: P-00R-VMQ
Abstract (EN): Here, we present the molecular diagnosis of a patient with a general clinical suspicion of Mucopolysaccharidosis, highlighting the different tools used to perform its molecular characterization. In order to decrease the turnaround time for the final report and contribute to reduce the "diagnostic odyssey", which frequently afflicts affected families, the proband's sample was simultaneously screened for mutations in a number of lysosomal function-related genes with targeted next-generation sequencing (NGS) protocol. After variant calling, the most probable cause for disease was a novel ARSB intronic variant, c.1213 +5G >T [IVS6 +5G >T], detected in homozygosity. In general, homozygous or compound heterozygous mutations in the ARSB gene, underlie MPS type VI or Maroteaux-Lamy syndrome. Still, even though the novel c.1213 +5G >T variant was easy to detect by both NGS and Sanger sequencing, only through indirect studies and functional analyses could we present proof of principle on its pathogenicity. Globally, this case reminds us that whenever a novel variant is detected, its pathogenicity must be carefully assessed before a definitive diagnosis is established, while highlighting alternative approaches that may be used to assess its effect in the absence RNA/cDNA sample(s) from the proband. This is particularly relevant for intronic variants such as the one here reported. Special attention will be given to the use of reporter minigene systems, which may be constructed/designed to dissect the effect of this sort of alterations, providing an insight into their consequences over the normal pre-mRNA splicing process of the affected gene.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 11
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Sudden Cardiac Death: The Role of Molecular Autopsy with Next-Generation Sequencing (2025)
Another Publication in an International Scientific Journal
Fadoni, J; Santos, A; Amorim, A; Cainé, L
Software as a Medical Device (SaMD) in Digestive Healthcare: Regulatory Challenges and Ethical Implications (2024)
Another Publication in an International Scientific Journal
Mascarenhas, M; Martins, M; Ribeiro, T; Afonso, J; Cardoso, P; Mendes, F; Cardoso, H; Almeida, R; Ferreira, J; Fonseca, J; Macedo G
From Data to Insights: How Is AI Revolutionizing Small-Bowel Endoscopy? (2024)
Another Publication in an International Scientific Journal
Mota, J; Almeida, MJ; Mendes, F; Martins, M; Ribeiro, T; Afonso, J; Cardoso, P; Cardoso, H; Andrade, P; Ferreira, J; Mascarenhas, M; Macedo G
A Comprehensive Review of Artificial Intelligence and Colon Capsule Endoscopy: Opportunities and Challenges (2024)
Another Publication in an International Scientific Journal
Mota, J; Almeida, MJ; Mendes, F; Martins, M; Ribeiro, T; Afonso, J; Cardoso, P; Cardoso, H; Andrade, P; Ferreira, J; Macedo G; Mascarenhas, M
x Forecasting COVID-19 Severity by Intelligent Optical Fingerprinting of Blood Samples (2021)
Article in International Scientific Journal
Faria, SP; Carpinteiro, C; Pinto, V; Rodrigues, SM; Alves, J; Marques, F; Lourenco, M; Santos, PH; Ramos, A; Cardoso, MJ; guimaraes, jt; Rocha, S; Sampaio, P; Clifton, DA; Mumtaz, M; Paiva, JS

See all (34)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-27 at 01:18:48 | Privacy Policy | Personal Data Protection Policy | Whistleblowing